本文選題：右側(cè)旁道 + 射頻消融術(shù)��； 參考：《山東醫(yī)藥》2017年41期

【摘要】：目的探討Ensite Navx三維標(biāo)測系統(tǒng)指導(dǎo)下射頻消融術(shù)(RFCA)治療右側(cè)旁道(RAP)的效果。方法選取接受RFCA治療的111例RAP患者,將其分為觀察組57例及對(duì)照組54例,觀察組于Ensite Navx引導(dǎo)下行RFCA,對(duì)照組于傳統(tǒng)X線下行RFCA。比較兩組放置標(biāo)測導(dǎo)管過程中X線照射時(shí)間和曝光劑量、操作消融導(dǎo)管進(jìn)行標(biāo)測消融過程中X線照射時(shí)間和曝光劑量、手術(shù)時(shí)間、即刻成功率、并發(fā)癥等。結(jié)果觀察組、對(duì)照組放置標(biāo)測導(dǎo)管過程中X線照射時(shí)間分別為(2.2±1.2)、(2.3±1.1)min,曝光劑量分別為(1.5±1.1)、(1.4±1.0)m Gy,兩組比較,P均0.05。觀察組、對(duì)照組消融導(dǎo)管操作過程中X線照射時(shí)間分別為(2.3±1.2)、(14.2±3.5)min,X線曝光劑量分別為(2.5±1.0)、(18.9±5.6m)m Gy,兩組比較,P均0.05。觀察組、對(duì)照組手術(shù)全程X線照射時(shí)間分別為(5.3±2.9)、(16.8±4.2)min,總曝光劑量分別為(6.1±3.1)、(19.6±5.4)m Gy,兩組比較,P均0.05。觀察組、對(duì)照組手術(shù)時(shí)間分別為(43.9±13.6)、(54.9±15.7)min,兩組比較,P0.05。兩組均消融成功,術(shù)后隨訪3個(gè)月無復(fù)發(fā)病例。術(shù)中兩組均未出現(xiàn)相關(guān)并發(fā)癥。結(jié)論 Ensite Navx三維標(biāo)測系統(tǒng)指導(dǎo)下RFCA治療RAP的效果較好,可在一定程度上縮短總手術(shù)時(shí)間及曝光劑量,不增加手術(shù)相關(guān)并發(fā)癥的發(fā)生風(fēng)險(xiǎn)。
[Abstract]:Objective to investigate the effect of radiofrequency ablation (RFCA) guided by Ensite Navx three-dimensional mapping system in the treatment of right accessory pathway (AP). Methods 111 patients with RFCA were divided into observation group (n = 57) and control group (n = 54). The observation group was guided by Ensite Navx and the control group was treated with conventional X-ray. The X-ray irradiation time and exposure dose during catheter placement were compared between the two groups, and X-ray irradiation time and exposure dose, operation time, immediate success rate and complications were measured by ablation catheter mapping. Results in the observation group, the X-ray irradiation time and the exposure dose were 2.2 鹵1.2 鹵1.2 鹵1.1 min and 1.4 鹵1.0 mGy, respectively, in the control group. The comparison was made between the two groups (P < 0.05). In the observation group, the time of X-ray irradiation during catheter ablation in the control group was 2.3 鹵1.2 min ~ (-1) and 14.2 鹵3.5 min ~ (-1), respectively. The exposure dose of X ray in the control group was (2.5 鹵1.0) min ~ (-1) (18.9 鹵5.6m)m ~ (-1) Gy), respectively, and the two groups were compared with each other (P < 0.05). In the observation group, the total exposure dose was 19.6 鹵5.4mGy and the total exposure dose was 6.1 鹵3.1mGy, respectively. The X-ray irradiation time of the control group was 5.3 鹵2.9g / min, respectively, and the total exposure dose was 0.05g / min. The results were as follows: (1) in the control group, the total exposure dose was 19.6 鹵5.4mGy (P = 0.05). In the observation group, the operative time in the control group was 43.9 鹵13.6 min, respectively, 54.9 鹵15.7min, compared with P0.05in the two groups. Ablation was successful in both groups, and no recurrence occurred after 3 months follow-up. There were no related complications in both groups. Conclusion RFCA under the guidance of Ensite Navx three-dimensional mapping system is effective in the treatment of RAP. It can shorten the total operative time and exposure dose to some extent and does not increase the risk of complications associated with surgery.
【作者單位】： 新疆醫(yī)科大學(xué);新疆醫(yī)科大學(xué)附屬中醫(yī)醫(yī)院·新疆維吾爾自治區(qū)中醫(yī)藥研究院;
【分類號(hào)】：R541.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 施海峰;劉旭;王新華;顧佳寧;孫育民;周立;胡偉;方唯一;;三維標(biāo)測系統(tǒng)指導(dǎo)下射頻消融局灶性房性心動(dòng)過速47例臨床評(píng)價(jià)[J];國際心血管病雜志;2008年01期

2 董建增;;三維標(biāo)測系統(tǒng)指導(dǎo)下的肺靜脈前庭隔離術(shù)[J];現(xiàn)代實(shí)用醫(yī)學(xué);2006年04期

3 鄭亞西;楊輝;劉曉橋;范壽年;劉志琴;;三維標(biāo)測系統(tǒng)技術(shù)指導(dǎo)下房顫射頻消融的初步體會(huì)[J];貴州醫(yī)藥;2008年12期

4 張志輝;曹宇;歐陽茂;楊侃;張夢璽;;非接觸三維標(biāo)測系統(tǒng)指導(dǎo)下環(huán)肺靜脈電隔治療心房顫動(dòng)的臨床評(píng)價(jià)[J];中南大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2007年05期

5 王洪;洪浪;賴珩莉;陳再華;邱，

本文編號(hào)：1916523